NCT07217002

Brief Summary

The goal of this project is to reduce unnecessary antibiotic use for children with ARTIs (Acute Respiratory Tract Infections) by implementing "outpatient antibiotic stewardship" across the Children's Hospital of Philadelphia (CHOP) Primary and Urgent Care Network to:

  1. 1.Reduce unnecessary antibiotic prescribing for the most common infections in children.
  2. 2.Reduce unnecessary a) broad-spectrum and b) longer-course antibiotic therapy for ear infections, Strep throat, sinus infections, and pneumonia.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for all trials

Timeline
36mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Feb 2025May 2029

Study Start

First participant enrolled

February 18, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

October 9, 2025

Last Update Submit

April 9, 2026

Conditions

Keywords

AntibioticsAntimicrobial Stewardship

Outcome Measures

Primary Outcomes (4)

  • Antibiotic Prescribing Rates for Acute Respiratory Tract Infections (ARTIs)

    ARTIs as measured by overall rates of prescribing an antibiotic during clinic visits for an acute respiratory tract infection (URI) diagnosis, including both bacterial and viral URIs using the EHR (electronic health record). Goal is that antibiotics are prescribed at 40% or fewer ARTI visits. The optimal proportion of ARTI visits that should be associated with an antibiotic prescription is unknown. Baseline prescribing rates for antibiotics in the Network ranges from 34-61%. The target 40% rate is currently achieved by 10% of our practices with the lowest antibiotic prescribing.

    From start of implementation ramp up period to end of year 2 implementation

  • Change in overall optimal antibiotic prescribing rates for all bacterial ARTI encounters

    Changing overall antibiotic prescribing rates as measured by a composite of 1) narrow antibiotic selection and 2) shortest effective duration as a proportion of all antibiotics prescribed for each of the target diagnoses: Acute otitis media, Group A streptococcal pharyngitis, Acute sinusitis, and Pneumonia using EHR (electronic health record) data. This metric combines both narrow-spectrum antibiotic choice and optimal durations of therapy to comprehensively evaluate optimal antibiotic prescribing. At least 90% of antibiotics prescribed for ARTI are for optimal short duration and narrow spectrum antibiotics

    From start of implementation ramp up period to end of year 2 implementation

  • Broad- versus Narrow-Spectrum Antibiotic Prescribing

    Broad vs. Narrow-Spectrum antibiotic prescribing as measured by rates of broad-spectrum antibiotics as a proportion of all antibiotics prescribed within each of these diagnoses using the EHR (electronic health record): * acute otitis media * Group A streptococcal pharyngitis * acute sinusitis * pneumonia At least 90% of antibiotics prescribed for ARTI are for optimal narrow spectrum antibiotics.

    From start of implementation ramp up period to end of year 2 implementation

  • Shortest Effective Duration Antibiotic Prescribing

    Shortest effective duration measured by rates of prescribing the shortest effective duration of antibiotics as a proportion of all antibiotics prescribed within each of these diagnoses: * acute otitis media * Group A streptococcal pharyngitis * acute sinusitis * pneumonia At least 90% of antibiotics prescribed for ARTI are for the shortest effective duration of antibiotics. Optimizing durations of therapy will reduce overall antibiotic days and, therefore, decrease the overall antibiotic burden for children with ARTIs.

    From start of implementation ramp up period to end of year 2 implementation

Secondary Outcomes (3)

  • Treatment failure or modification 14 days

    14 days

  • Antibiotic-associated adverse events (AEs) within 7 days of completing antibiotics

    From index visit to 7 days of completing antibiotics

  • Group A Strep Testing

    From start of implementation ramp up period to end of year 2 implementation

Study Arms (1)

CHOP Primary Care Providers

Providers at all 30 primary care practice offices and 4 urgent care offices that include physicians and Advanced Practice Provider (APPs) including Nurse Practitioners (NPs) and Physicians Assistants (PAs).

Other: Online Educational ModulesOther: Prescribing Feedback ReportsOther: Clinical Decision SupportOther: Live, hybrid in-person and online educational sessions

Interventions

Online educational modules for clinicians that describe optimal antibiotic use and provide strategies to communicate with families about antibiotic prescribing for ARTIs. Modules are assigned through CHOP's internal learning website and assigned to every single primary care provider.

CHOP Primary Care Providers

Prescribing feedback reports distributed quarterly that show clinicians how their prescribing and Group A Strep testing compares to their peers and to professional guideline recommendations. Will include metrics of overall prescribing and show choice and duration for antibiotics given ear infections, Strep throat, sinus infections, and pneumonia. The goal of the feedback reports is to show clinicians how often they are prescribing antibiotics, and when they do prescribe antibiotics are they doing so with right antibiotic and for the correct duration.

CHOP Primary Care Providers

Clinical decision support built into the electronic health record to help clinicians choose the right antibiotics for the right number of days. Using information from guidelines and clinical pathways created by CHOP to help providers continue to optimize their prescribing practices.

CHOP Primary Care Providers

Live, hybrid in-person and online educational sessions that explain the project, describe best prescribing practices and allow clinicians to talk directly with project team members. Study leaders visit all 31 practices across the network.

CHOP Primary Care Providers

Eligibility Criteria

Age6 Months - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

In two years, the project team will reach all 121,000 children 6 months to 12 years of age seen at 288,000 encounters for ARTIs at the Primary Care Practices and Urgent Care locations across the CHOP primary care and urgent care network.

You may qualify if:

  • Severe immunocompromised status OR tracheostomy dependence
  • Children with other bacterial infection diagnoses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Community-Acquired PneumoniaSinusitisOtitis Media

Condition Hierarchy (Ancestors)

Community-Acquired InfectionsInfectionsPneumoniaRespiratory Tract InfectionsRespiratory Tract DiseasesParanasal Sinus DiseasesNose DiseasesOtorhinolaryngologic DiseasesOtitisEar Diseases

Study Officials

  • Rebecca Same, MD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR
  • Louis Bell, MD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2025

First Posted

October 15, 2025

Study Start

February 18, 2025

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2029

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations